Impact of Omega-3 Enriched Chicken and Eggs on Blood Levels in Healthy Adults
Omega-3-Index Response to Eating Poultry Foods Naturally Enriched With Omega-3 Polyunsaturated Fatty Acids: A Randomized Controlled Trial in Healthy Saudi Adults
This study is testing if eating chicken and eggs that are enriched with omega-3 can increase omega-3 levels in healthy adults.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 80 (estimated) |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Sponsor | King Abdulaziz University Academic / other |
| Locations | 1 site (Jeddah) |
| Trial ID | NCT06259825 on ClinicalTrials.gov |
What this trial studies
This interventional trial aims to evaluate the effects of consuming omega-3 polyunsaturated fatty acid (PUFA) enriched chicken-meat and eggs on the omega-3 index in healthy Saudi adults. Participants will be randomized to consume either the enriched foods or standard poultry products over a four-month period. The primary outcome will measure changes in red blood cell levels of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Secondary objectives include comparing omega-3 levels between regular oily fish consumers and non-consumers.
Who should consider this trial
Good fit: Ideal candidates are healthy adults aged 18 to 70 who regularly consume chicken and eggs.
Not a fit: Patients with significant cardiovascular disease, mental health issues, or those taking omega-3 supplements may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a dietary solution to increase omega-3 levels in individuals who do not consume sufficient seafood.
How similar studies have performed: While the approach of using enriched poultry foods is innovative, similar studies have shown positive outcomes in increasing omega-3 levels through dietary interventions.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults (≥ 18 years and \< 70 years) * Regular consumers (≥ 4 portions weekly) or willing to be regular consumers of chicken-meat. * Regular consumers (≥ 4 eggs weekly) or willing to be regular consumers of eggs. * Able to give informed consent. Exclusion Criteria: * Concurrent or recent (within last 3 months) regular intake of long-chain omega-3-PUFA supplements (containing EPA, DPA and/or DHA). * Previous diagnosis of; * significant cardiovascular disease (e.g. myocardial infarction, coronary intervention, or stroke), * significant mental ill-health (e.g. major depression, psychosis or dementia) or * a haemoglobinopathy such as sickle cell anaemia or thalassemia . * Any other serious medical condition that may adversely affect the patient's safety, limit the subject's ability to participate in the study, comply with follow-up requirements or impact the scientific integrity of the study.
Where this trial is running
Jeddah
- Department of Food Science and Nutrition, King Abdulaziz University — Jeddah, Saudi Arabia (Recruiting)
Study contacts
- Principal investigator: Salwa Albar, BSc, PhD — King Abdulaziz University
- Study coordinator: Alice V Stanton, MB, PhD
- Email: astanton@rcsi.ie
- Phone: +353872885480
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.